PCSK9 and cardiovascular disorder: Several studies have shown the positive association between PCSK9 and triglycerides levels [6, 7, 9], and PCSK9 inhibition has been demonstrated to influence triglyceride-rich lipoprotein metabolism which is also a risk factor for cardiovascular disease and vascular inflammation [28, 29].